European Innovation Council

AMT Medical B.V., established in 2015 and located in Ede, the Netherlands, specializes in the development of innovative medical devices for heart bypass surgery. The company's flagship product, the AMT Heart Bypass System, utilizes a minimal invasive technique known as the ELANA bypass, which was invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team. This advanced technology aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, thereby improving patient outcomes and reducing complications. AMT Medical has completed the full development of its product and the production process, with all pre-clinical trials successfully concluded. The company is also preparing to initiate a clinical multi-center trial to further validate the technology's efficacy.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

Photon IP is a deeptech startup located in Eindhoven, the Netherlands, specializing in the development of advanced technologies for photonics applications. The company focuses on creating application-specific semiconductors that cater to various industries, including automotive and telecommunications. Its innovative products are designed to enhance the production of wearable electronics and improve data center operations, providing tailored solutions that address the evolving needs of its clients.

GBM Works B.V., founded in 2016 and headquartered in The Hague, Netherlands, specializes in the installation of offshore wind turbine foundations. The company has developed an innovative technique known as the GBM Vibro-drill, which allows for the silent installation of these foundations. This method aims to minimize ocean noise and its impact on marine ecosystems and nearby communities, thereby facilitating the growth of the renewable energy sector's offshore operations. GBM Works combines conventional installation techniques with advanced technology to enhance the efficiency and sustainability of offshore wind energy projects.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Axelera AI is a company focused on advancing artificial intelligence through its specialized hardware and software platforms, particularly for edge computing applications. Its flagship product, the Metis™ AI Platform, combines innovative hardware and software to offer high-performance and energy-efficient AI inference solutions. Recognized for its innovation, the platform was honored at the CES® 2024 Innovation Awards. Established in 2021, Axelera AI was incubated by Bitfury, a leader in emerging technologies, and partnered with imec, a prominent nano-technology group. The company is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices located in Belgium, Switzerland, and Italy. The team consists of experts in AI software and hardware, many of whom have backgrounds with leading AI firms and Fortune 500 companies. Axelera AI’s platform features a unique custom dataflow architecture with multicore in-memory computing, enabling clients to achieve optimal power efficiency while supporting various networks for sustainable edge applications.

Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.

E-peas SA is a Belgian company established in 2014, specializing in the design and manufacturing of electronic systems that provide energy autonomy for Internet of Things (IoT) applications. The company develops innovative energy harvesting solutions that enable devices to draw energy from various ambient sources, including solar, thermal, vibration, and radiofrequency. E-peas produces energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and longevity of IoT devices by either extending battery life or eliminating the need for batteries altogether. Their technology caters to a wide range of sectors, including home automation, healthcare, retail, and agriculture, thereby facilitating the creation of smarter and more energy-efficient connected devices. Headquartered in Mont-Saint-Guibert, Belgium, E-peas aims to transform the landscape of portable energy solutions.

Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in the development of innovative solutions for microsurgery, focusing on enhancing surgical performance through its motion stabilizer system. This device assists microsurgeons by scaling down motion and filtering out tremors, thereby providing extraordinary control and precision during procedures. The system aims to improve the quality of microsurgical operations, enabling the exploration of new and highly accurate surgical techniques that were previously unavailable. Microsure's technology has been successfully tested in clinical trials, demonstrating its effectiveness in lymphedema surgeries. By facilitating the use of surgeons' own micro-instruments, the device also aims to reduce costs for healthcare facilities while increasing the number of treatment options available for patients.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Plasmacure, headquartered in Eindhoven, Netherlands, is a medical technology company focused on developing innovative solutions for chronic wound healing, with a particular emphasis on diabetic foot wounds. The company's core product is a patented cold plasma solution designed to kill bacteria, stimulate cell proliferation, and improve microcirculation, thereby reducing the risk of amputation and enhancing patients' quality of life.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in deep thermotherapy specifically for head and neck cancer treatment. The company has developed a unique medical device that employs proprietary thermal technology and interactive software to provide localized heating, enhancing the effectiveness of conventional therapies like radiotherapy and chemotherapy, which often have toxic side effects. Sensius' innovative approach has shown promising results, with a study indicating that 81.8% of treated patients achieved a complete response within 12 weeks of radiotherapy. With interest from twenty potential buyers, Sensius is in the process of obtaining CE marking for its device and has plans to expand its applications to other types of cancer in the future.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in deep thermotherapy specifically for head and neck cancer treatment. The company has developed a unique medical device that employs proprietary thermal technology and interactive software to provide localized heating, enhancing the effectiveness of conventional therapies like radiotherapy and chemotherapy, which often have toxic side effects. Sensius' innovative approach has shown promising results, with a study indicating that 81.8% of treated patients achieved a complete response within 12 weeks of radiotherapy. With interest from twenty potential buyers, Sensius is in the process of obtaining CE marking for its device and has plans to expand its applications to other types of cancer in the future.

N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

Dimenco B.V. is a prominent 3D technology company based in Veldhoven, the Netherlands, specializing in autostereoscopic solutions that enhance visual experiences without the need for glasses. Founded in 2010, Dimenco develops advanced 3D displays and components, alongside software and content conversion services tailored for both professional and consumer markets. The company's innovative offerings include DirectX and OpenGL visualizers that facilitate the viewing of 3D applications on their specialized displays, as well as tools like the Dimenco 3D Player for playing 3D video clips and the Dimenco Control Tool for adjusting visualization parameters. Dimenco has established itself as a leader in providing immersive and realistic visual technology, making significant strides in the realm of simulated reality.

FOx Biosystems is a biotechnology company focused on enhancing biomolecular interaction analysis for life science research and industry. Founded in 2017 by Filip Delport and Jeroen Lammertyn, and based in Temse, Oost-Vlaanderen, Belgium, the company specializes in developing custom applications, including probes and devices, to support various research needs. FOx Biosystems employs real-time, label-free analysis technology that offers significant advantages over traditional biomolecular analysis tools, such as ease of use, speed, and cost-effectiveness. This technology enables healthcare companies and researchers to obtain high-quality biomolecular data, including concentration measurements, affinity data, and kinetic data, ultimately aiming to transform the life sciences sector.

AugmedIT B.V. is a medical software company founded in 2018 and located in Amsterdam, the Netherlands. The company specializes in developing augmented and mixed reality tools that enhance surgical procedures by enabling surgeons to create holograms of patients. AugmedIT's technology focuses on applications in neurosurgery, medical education, holographic visualization, and neuronavigation, aiming to improve precision and outcomes in medical practice through innovative visualization techniques.

Dimenco B.V. is a prominent 3D technology company based in Veldhoven, the Netherlands, specializing in autostereoscopic solutions that enhance visual experiences without the need for glasses. Founded in 2010, Dimenco develops advanced 3D displays and components, alongside software and content conversion services tailored for both professional and consumer markets. The company's innovative offerings include DirectX and OpenGL visualizers that facilitate the viewing of 3D applications on their specialized displays, as well as tools like the Dimenco 3D Player for playing 3D video clips and the Dimenco Control Tool for adjusting visualization parameters. Dimenco has established itself as a leader in providing immersive and realistic visual technology, making significant strides in the realm of simulated reality.

Circu Li-ion is a Luxembourg-based start-up focused on automated battery disassembly and diagnostics to enhance the remanufacturing, reuse, and recycling of lithium-ion batteries. The company's proprietary platform integrates three key components: a battery library, an application layer, and robotic disassembly systems. These technologies enable significant cost reductions by decreasing dependence on manual labor and indirect expenses while achieving high levels of robot autonomy to enhance safety and efficiency. Circu Li-ion's automated processes maximize material recovery, allowing for up to 95% of battery components to be reused or recycled effectively. By employing advanced computer vision models and robotic systems, the start-up caters to the diverse designs of batteries, helping businesses reduce costs, address labor shortages, and mitigate environmental impacts associated with traditional recycling methods.

Born from the MRCLEAN trial, NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Center. Our research background continues to drive our way of thinking. The team consists of researchers, developers and experienced medical specialists to ensure we align with our clients needs. We believe connecting human & artificial intelligence will revolutionize emergency care. Our cloud-based solution, StrokeViewer, automatically analyses brain CT scans and gives results within minutes. StrokeViewer empowers physicians in the emergency setting to provide patients with the right treatment in time.

Dawn Aerospace is a company that specializes in designing and manufacturing reusable spacecraft for satellite launches. Founded in 2016 and headquartered in Delft, Netherlands, with additional facilities in Auckland, New Zealand, the company offers various vehicles, including the MK-1, MK-2, MK-3, and MK-4. Dawn Aerospace is focused on developing same-day reusable launch vehicles that can operate without specialized space-launch infrastructure, allowing them to integrate seamlessly with existing air traffic. Additionally, the company provides non-toxic propulsion systems for satellites, which replace harmful fuels like hydrazine and enhance performance for small satellites and CubeSats significantly. By creating these technologies in tandem, Dawn Aerospace aims to establish an efficient, scalable, and environmentally conscious architecture for satellite deployment and operations.

AMT Medical B.V., established in 2015 and located in Ede, the Netherlands, specializes in the development of innovative medical devices for heart bypass surgery. The company's flagship product, the AMT Heart Bypass System, utilizes a minimal invasive technique known as the ELANA bypass, which was invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team. This advanced technology aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, thereby improving patient outcomes and reducing complications. AMT Medical has completed the full development of its product and the production process, with all pre-clinical trials successfully concluded. The company is also preparing to initiate a clinical multi-center trial to further validate the technology's efficacy.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

GBM Works B.V., founded in 2016 and headquartered in The Hague, Netherlands, specializes in the installation of offshore wind turbine foundations. The company has developed an innovative technique known as the GBM Vibro-drill, which allows for the silent installation of these foundations. This method aims to minimize ocean noise and its impact on marine ecosystems and nearby communities, thereby facilitating the growth of the renewable energy sector's offshore operations. GBM Works combines conventional installation techniques with advanced technology to enhance the efficiency and sustainability of offshore wind energy projects.

SolarDew is a Netherlands-based company that specializes in innovative membrane distillation technology for water desalination and purification. The firm focuses on transforming contaminated, tainted, or saline water into pure drinking water. Its modular systems are powered exclusively by solar energy, eliminating the need for external energy sources. This approach not only enhances the sustainability of water purification efforts but also empowers local entrepreneurs to establish and operate their own water treatment businesses within their communities. By leveraging renewable energy, SolarDew aims to provide accessible and safe drinking water solutions globally.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

E-peas SA is a Belgian company established in 2014, specializing in the design and manufacturing of electronic systems that provide energy autonomy for Internet of Things (IoT) applications. The company develops innovative energy harvesting solutions that enable devices to draw energy from various ambient sources, including solar, thermal, vibration, and radiofrequency. E-peas produces energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and longevity of IoT devices by either extending battery life or eliminating the need for batteries altogether. Their technology caters to a wide range of sectors, including home automation, healthcare, retail, and agriculture, thereby facilitating the creation of smarter and more energy-efficient connected devices. Headquartered in Mont-Saint-Guibert, Belgium, E-peas aims to transform the landscape of portable energy solutions.

SolarDew is a Netherlands-based company that specializes in innovative membrane distillation technology for water desalination and purification. The firm focuses on transforming contaminated, tainted, or saline water into pure drinking water. Its modular systems are powered exclusively by solar energy, eliminating the need for external energy sources. This approach not only enhances the sustainability of water purification efforts but also empowers local entrepreneurs to establish and operate their own water treatment businesses within their communities. By leveraging renewable energy, SolarDew aims to provide accessible and safe drinking water solutions globally.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Allero Therapeutics B.V. is a biopharmaceutical company based in Rotterdam, the Netherlands, that focuses on developing programmed immunotherapies for immune-mediated disorders. Founded in 2016, the company leverages its Specific Oromucosal Immunotherapy (SOMIT) platform, which aims to restore immune tolerance through the targeted delivery of antigen-specific treatments. This innovative approach is rooted in the founders' research and is designed to induce long-lasting antigen-specific tolerance, addressing a range of clinical indications, particularly in the fields of allergic and autoimmune diseases. By targeting profound unmet medical needs, Allero Therapeutics is positioned to advance next-generation immunotherapies that have the potential to significantly improve patient outcomes.

Do you want to use your green roof to power your house? Would you like to see each wetland and rice paddy field in the world turned into a power plant without harvesting the plants? Plant-e is a company that develops and produces products in which living plants generate electricity. The company was founded on September 14, 2009 as a spin-off from the sub-department of Environmental Technology of Wageningen University by Marjolein Helder and David Strik. Since her PhD-graduation in November 2012 Marjolein is working full-time as CEO of Plant-e. David works as an assistant professor at Wageningen University and still is an important link between scientific research and the research and development at Plant-e.

N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in deep thermotherapy specifically for head and neck cancer treatment. The company has developed a unique medical device that employs proprietary thermal technology and interactive software to provide localized heating, enhancing the effectiveness of conventional therapies like radiotherapy and chemotherapy, which often have toxic side effects. Sensius' innovative approach has shown promising results, with a study indicating that 81.8% of treated patients achieved a complete response within 12 weeks of radiotherapy. With interest from twenty potential buyers, Sensius is in the process of obtaining CE marking for its device and has plans to expand its applications to other types of cancer in the future.

Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in the development of innovative solutions for microsurgery, focusing on enhancing surgical performance through its motion stabilizer system. This device assists microsurgeons by scaling down motion and filtering out tremors, thereby providing extraordinary control and precision during procedures. The system aims to improve the quality of microsurgical operations, enabling the exploration of new and highly accurate surgical techniques that were previously unavailable. Microsure's technology has been successfully tested in clinical trials, demonstrating its effectiveness in lymphedema surgeries. By facilitating the use of surgeons' own micro-instruments, the device also aims to reduce costs for healthcare facilities while increasing the number of treatment options available for patients.

Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.

Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.

E-peas SA is a Belgian company established in 2014, specializing in the design and manufacturing of electronic systems that provide energy autonomy for Internet of Things (IoT) applications. The company develops innovative energy harvesting solutions that enable devices to draw energy from various ambient sources, including solar, thermal, vibration, and radiofrequency. E-peas produces energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and longevity of IoT devices by either extending battery life or eliminating the need for batteries altogether. Their technology caters to a wide range of sectors, including home automation, healthcare, retail, and agriculture, thereby facilitating the creation of smarter and more energy-efficient connected devices. Headquartered in Mont-Saint-Guibert, Belgium, E-peas aims to transform the landscape of portable energy solutions.

Avy is an Amsterdam-based technology company that develops, manufactures, and operates vertical takeoff and landing (VTOL) winged drones. Focusing on emergency services and healthcare logistics, Avy's drone networks provide autonomous solutions that allow emergency response providers, including fire departments, police, and ambulance services, to reach critical locations within minutes. The company offers a comprehensive product portfolio, including its drones and an all-in-one service designed to facilitate medical deliveries. Avy emphasizes sustainability with its zero-emission drones, enabling clients to achieve greater operational autonomy and significant reductions in response times and costs.

Avy is an Amsterdam-based technology company that develops, manufactures, and operates vertical takeoff and landing (VTOL) winged drones. Focusing on emergency services and healthcare logistics, Avy's drone networks provide autonomous solutions that allow emergency response providers, including fire departments, police, and ambulance services, to reach critical locations within minutes. The company offers a comprehensive product portfolio, including its drones and an all-in-one service designed to facilitate medical deliveries. Avy emphasizes sustainability with its zero-emission drones, enabling clients to achieve greater operational autonomy and significant reductions in response times and costs.

Hiber Global, founded in 2016 and based in Amsterdam, Netherlands, specializes in providing satellite broadband services and affordable IoT connectivity through its Hiberband technology. The company has developed a nano-satellite platform that enables low-cost data transmission for Internet of Things (IoT) devices and sensors worldwide. This platform facilitates easy access to low-power networks, allowing users to gather small data packages from diverse monitoring devices, regardless of their location. Hiber's innovative solutions deliver actionable insights, making it a leader in next-generation IoT core infrastructure.

Plasmacure, headquartered in Eindhoven, Netherlands, is a medical technology company focused on developing innovative solutions for chronic wound healing, with a particular emphasis on diabetic foot wounds. The company's core product is a patented cold plasma solution designed to kill bacteria, stimulate cell proliferation, and improve microcirculation, thereby reducing the risk of amputation and enhancing patients' quality of life.

Plasmacure, headquartered in Eindhoven, Netherlands, is a medical technology company focused on developing innovative solutions for chronic wound healing, with a particular emphasis on diabetic foot wounds. The company's core product is a patented cold plasma solution designed to kill bacteria, stimulate cell proliferation, and improve microcirculation, thereby reducing the risk of amputation and enhancing patients' quality of life.

S-Biomedic is a Belgian biotech company specializing in live probiotic cosmetics that target the skin microbiome. Based in Beerse, the company develops innovative skincare solutions aimed at addressing various skin conditions such as acne, eczema, rosacea, and signs of aging. By employing a targeted modulation-based technology, S-Biomedic selects and combines beneficial bacteria to rebalance the skin’s microbiome, thus restoring its health. Their products are formulated using advanced microbiological and dermatological research, allowing them to effectively contribute to skin health and beauty. Through their novel approach, S-Biomedic offers a new class of therapeutic options for both dermatological and cosmetic applications.

S-Biomedic is a Belgian biotech company specializing in live probiotic cosmetics that target the skin microbiome. Based in Beerse, the company develops innovative skincare solutions aimed at addressing various skin conditions such as acne, eczema, rosacea, and signs of aging. By employing a targeted modulation-based technology, S-Biomedic selects and combines beneficial bacteria to rebalance the skin’s microbiome, thus restoring its health. Their products are formulated using advanced microbiological and dermatological research, allowing them to effectively contribute to skin health and beauty. Through their novel approach, S-Biomedic offers a new class of therapeutic options for both dermatological and cosmetic applications.

Tessares is a Belgian company founded in 2015, specializing in software solutions that enhance Internet access performance and quality. Based in Louvain-La-Neuve, Tessares focuses on its Hybrid Access Solution, which utilizes standardized Multipath TCP technology to improve Internet speeds by bonding multiple access network technologies. This innovative approach allows network operators to deliver faster Internet service to customers without necessitating extensive infrastructure changes. The company's expertise stems from key developers of the Multipath TCP protocol, enabling it to create effective software-based solutions that optimize the Internet experience across diverse geographic areas. Tessares operates as a privately-owned entity and has attracted significant funding to support its growth and technological advancements.

Tessares is a Belgian company founded in 2015, specializing in software solutions that enhance Internet access performance and quality. Based in Louvain-La-Neuve, Tessares focuses on its Hybrid Access Solution, which utilizes standardized Multipath TCP technology to improve Internet speeds by bonding multiple access network technologies. This innovative approach allows network operators to deliver faster Internet service to customers without necessitating extensive infrastructure changes. The company's expertise stems from key developers of the Multipath TCP protocol, enabling it to create effective software-based solutions that optimize the Internet experience across diverse geographic areas. Tessares operates as a privately-owned entity and has attracted significant funding to support its growth and technological advancements.

Hiber Global, founded in 2016 and based in Amsterdam, Netherlands, specializes in providing satellite broadband services and affordable IoT connectivity through its Hiberband technology. The company has developed a nano-satellite platform that enables low-cost data transmission for Internet of Things (IoT) devices and sensors worldwide. This platform facilitates easy access to low-power networks, allowing users to gather small data packages from diverse monitoring devices, regardless of their location. Hiber's innovative solutions deliver actionable insights, making it a leader in next-generation IoT core infrastructure.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.